EMEA-000420-PIP01-10
Key facts
Invented name |
|
Active substance |
duloxetine hydrochloride
|
Therapeutic area |
Uro-nephrology
|
Decision number |
P/268/2010
|
PIP number |
EMEA-000420-PIP01-10
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Eli Lilly & Company Limited
E-mail: eu_paediatric@lilly.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|